| Videos | Channels | Search |
The value of Spin-outs by Martin Bonde, Chairman Dansk Biotek and Copenhagen Spin-outs
What is the societal value of public biotech Spin-outs? Where is the link to industry and how should central administration support it? Martin Bonde explains what it takes to make it and what value it provides.
31:45 minutes
Tags: IPR, biotech, biotek, capital, creation, danish, dansk, job, region, research, talents, technology transfer
Switch to